Charles River Laboratories (Wilmington, MA) is a global early-stage CRO. 2024 revenue ~$4.1B. Preclinical, DMPK, safety assessment, animal models. Acquired Citoxlab, Vigene Biosciences. Gene therapy CDMO services.
12:41:36 AM · Jul 9, 2026
Sign in to reply and join the conversation.